Insider insights on pharma career strategy, the DACH job market, LinkedIn, ATS systems, and executive recruitment. The knowledge that comes from 17 years on the other side of the desk, written for the candidates who deserve to know it.
Both camps quote the same three surveys. One dataset measured candidate quality against the badge in two labour markets, and the result flipped with the market.
Read article →The 75% figure traces to a vendor that folded in 2013. In Germany 1% of employers pre-screen with AI. The real gates are knockout questions, gap filters and a rule Brussels just moved to 2027.
Read article →A reverse recruitment firm took $10,000 up front and delivered zero interviews in ninety days. German law caps placement fees at €2,000 and bans advance payment. Here is how to check a provider.
Read article →Public employers in Germany owe you a salary figure before the interview since 8 June 2026. Private employers owe nothing until 2028. What to ask, and when.
Read article →Roughly one advert in five is a ghost job. The German numbers explain why, and they are stranger than the conspiracy theory.
Read article →48% fewer callbacks at 50, €7,500 for one ageist job advertisement, and 13.3 million people reaching retirement age by 2040. The full age file, with the numbers.
Read article →Knockout questions, gap filters, keyword mismatch, parsing failure: the four gates that decide whether a human ever reads your pharma application.
Read article →21 weeks for a master’s graduate, 13 for a bachelor’s, 40 applications per interview. The German entry level market, measured rather than described.
Read article →63.5% of applicants in Germany hear nothing back, and 45% of HR managers admit to ghost jobs. The three-week rule, the psychology of silence, and nine moves that work.
Read article →The applicant-to-interview rate is about 3% and the average opening draws 180 applicants. Here is why volume is the problem and what a quality strategy looks like in pharma.
Read article →Outplacement explained: who pays, who gets it, what happens phase by phase, how German, Austrian and Swiss rules touch it, and how to tell a good provider from a bad one.
Read more →What § 70 StrlSchG puts on the Strahlenschutzbeauftragter, which Fachkunde the law demands, how often it has to be refreshed, and who appoints one in pharma and medtech.
Read more →Who has to appoint a Gefahrgutbeauftragter, which exemptions apply, what the IHK Schulungsnachweis covers, and which UN numbers a pharma or medtech site actually ships.
Read more →What Article 97 of Regulation (EU) 2019/6 demands of the veterinary qualified person, how it differs from § 14 AMG, and where the German jobs sit under the TAMG.
Read more →What Articles 4 and 5 of Regulation (EC) 1223/2009 put on the responsible person, why the Article 10(2) diploma belongs to the safety assessor, and how Germany enforces it.
Read more →Pharmaingenieur is a job title, not a statutory appointment. What the work covers on a German site, which GMP rules bind it, and where it sits next to the named persons.
Read more →Medizintechnik-Ingenieur is a job title, not a statutory appointment. What the MDR binds on the manufacturer side, what the 2025 MPBetreibV binds in hospitals, and who hires.
Read more →Legal basis, who must appoint, and what each qualification test demands, with a career guide behind every role.
Read more →What the role owns behind the German wholesale licence, why the 2020 court ruling widened who qualifies, and the route in.
Read more →The Article 15 duties, the two qualification routes, and what replaced the German Sicherheitsbeauftragter.
Read more →The qualification routes, the reporting duty, and why clinical staff get hired into medtech field teams.
Read more →What the § 3 BtMG licence demands of the named person, which expertise routes § 6 BtMG accepts, and who is hiring.
Read more →The three qualification routes, why the Pharmareferent certificate is only one of them, and the duties in § 76.
Read more →What each function owns, why the two must stay independent, and how they relate to the Qualified Person.
Read more →The qualification written into the provision, what the seat answers for, and the realistic routes in.
Read more →Who has to appoint one, what the role owns, and why it works as a bridge from the clinic into medtech.
Read more →What the role under § 63a AMG actually does, the qualifications German authorities expect, and how it leads to the EU QPPV.
Read more →What Germany's mandatory information officer owns, the qualifications that count, and the career route into the appointment.
Read more →The § 15 AMG requirements, the realistic route through QC and QA to batch certification, and what the DACH market demands.
Read more →The qualifications, the realistic entry routes, and what recruiters and the ATS actually check for CRA roles.
Read more →What drives each promotion from RA Officer to Head of Regulatory Affairs, and how to position for the next rung.
Read more →The entry routes into drug safety that actually work, and what a pharmacovigilance CV must show.
Read more →How to reframe your GMP experience for a move into QA, and what a QA CV must evidence.
Read more →An insider recruiter compares the two most popular pharma career paths and how to choose.
Read more →Why Market Access and HEOR careers command a premium, and how the AMNOG process shapes the field.
Read more →Germany cannot fill its vacancies yet screens out the over-fifties. Age discrimination in DACH pharma hiring in 2026, the data, the euphemisms, and five moves that actually work.
Read article →The '80% hidden job market' stat traces to a 1966 pamphlet. The real DACH numbers, the weak-ties science, and which networking actually works.
Read article →The most-reported LinkedIn job scam of 2026 is the fake recruiter who says your CV needs a paid rewrite. How it works, the one character that unmasks it, and how to stay safe.
Read article →54,000 German executives are unemployed, the highest since 2015. The DACH executive job market in 2026, the euphemisms, and five moves that actually work at any level.
Read article →AI auto-apply tools promise to job-hunt while you sleep. The data says they quietly torpedo your candidacy, and the EU AI Act regulates their robot, not yours.
Read article →22,000 Western pharma redundancies and a 62% Indian hiring surge are not separate phenomena. They are the same transaction. What it means for DACH pharma careers in 2026.
Read article →The '85% via networking' claim has no traceable source. The real number is 30–50% from referrals, and the actionable advice is more useful than the slogan.
Read article →Fourteen years watching pharma's technology waves. What AI will and won't take from medical writing, pharmacovigilance, biostatistics, and regulatory affairs in 2026.
Read article →Randstad Workmonitor 2026: 60% of German employees now rank job security above work-life balance. The data, the diagnosis, the strategy.
Read article →63.5% of applicants get no reply at all. The Indeed/Appinio survey, the EU Pay Transparency Directive (7 June 2026), and why pay transparency is the single biggest fix for ghosting in DACH pharma hiring.
Read article →Roughly 50–70% of senior DACH pharma roles are filled before they hit a job board. How to be the candidate recruiters source, not the one who applies in vain.
Read article →Germany's Opportunity Card is reshaping DACH pharma hiring competition. What it does, who is using it, and what it means for your salary and your next role.
Read article →Most pharma professionals treat LinkedIn as a CV. Recruiters read it as an argument. Here is how to write a profile that closes the case before paragraph two.
Read article →The honest answer from someone who screens CVs daily. What actually matters, what doesn't, and why the degree debate is more nuanced than LinkedIn thinks.
Read article →75% of CVs never reach a human recruiter, or do they? We separate ATS myth from reality, cover what DACH hiring actually looks like, and explain what changes from August 2026 under the EU AI Act.
Read article →93% of recruiters plan to increase AI use in 2026. Only 8% of candidates think AI makes hiring fair. What this really means for your pharma job search, and what the EU AI Act does about it.
Read article →Germany's four-day workweek trial results are in. What the data actually says about productivity, pharma hiring, and the future of work in DACH.
Read article →The EU Pay Transparency Directive is coming. How it reshapes pharmaceutical hiring in Germany, Austria, and Switzerland, and how to use it before everyone else does.
Read article →2027 is the year the patent cliff actually arrives, AI actually works, and your career either transforms or becomes obsolete. Here's the honest outlook.
Read article →180,000 new pharma jobs will be created in 2026, and 95,000 will be destroyed. Here's how to be on the right side of that equation.
Read article →The patent cliff, AI disruption, and an outdated CV, three forces converging in 2026. What pharma professionals need to do now.
Read article →Pharma has an SOP for everything, except basic human decency in hiring. Five measures that could fix recruitment ghosting.
Read article →Let's play a game called "Spot the Fiction", the uncomfortable truth about why your applications disappear into the void.
Read article →Job postings down 19%. Applications up 65%. Here's how to survive the most competitive pharma job market in a decade.
Read article →The pharma AI skills gap is 60%. For every 10 AI-competent candidates needed, only 4 exist. Here is what actually works to close that gap, and what is just expensive Quatsch.
Read article →42,700 pharmaceutical jobs eliminated in 2025 –47% worse than 2024. What's really happening and what will actually save your career.
Read article →The viral LinkedIn post shaming a recruiter might feel good, but it's quietly destroying your chances. Here's what actually happens behind the scenes.
Read article →A thought experiment that reveals uncomfortable truths about modern hiring, and what you can do about it.
Read article →A former Big-Pharma recruiter debunks the five biggest ATS myths, the automatic 75% rejection, keyword mirroring, white-text hacks, and what actually moves your application.
Read article →The algorithms that pharmaceutical companies use to filter CVs are not as random as they feel. Here is exactly how they work, and how to beat them.
Read article →LinkedIn removed 80.6 million fake accounts in six months. Job scams surged 1,000%. The red flags real recruiters spot, and the ones candidates miss.
Read article →After 17 years in pharmaceutical recruitment, some clients transformed their trajectories. Others burned through savings on glorified CV formatting services. Here's how to tell the difference.
Read article →Toyota became the world's largest car manufacturer through disciplined continuous improvement. The same principle applies to your pharma career, here's how.
Read article →220 million professionals now use LinkedIn's green "Open to Work" banner, a 35% surge. Is it helping or hurting your pharma job search?
Read article →After 17 years in pharmaceutical talent acquisition, watching exceptional candidates with decades of expertise get passed over, the age bias conversation pharma needs to have.
Read article →Stop sending your 847th application to a Senior Pharma role you're "technically qualified" for. Here's what actually gets you hired.
Read article →Yes, I said it. The badge that's supposed to help you get hired might be doing the opposite. Here's why, and what to do instead.
Read article →Learn in five minutes how LinkedIn connections and direct messages can become one of your best job-hunting tools in pharma.
Read article →It's not their experience. It's not their skills. After 17 years in pharma recruitment, I've seen exceptional candidates become invisible, because of acronyms.
Read article →If an employer you admire is hiring but has nothing that fits, pick up the phone. Why a two-minute call beats another cold application, from a recruiter who remembers the callers.
Read article →A journalist let AI bots apply to jobs on her behalf. The results: £200 spent, wrong languages claimed, cover letters sent to the wrong companies. As a recruiter, I can assure you: we notice.
Read article →After 17 years in pharma recruitment: degrees open doors, but skills decide what happens once you're inside. Here's the cheat sheet.
Read article →A recruiter's take on cybersecurity: after 17 years in talent acquisition, here's why WhatsApp's latest breach matters for your career and data.
Read article →AI, drug discovery, and the billion-euro question: should pharmaceutical companies build their own supercomputers or rent someone else's?
Read article →Europe's 80% dependency on Asian pharmaceutical ingredients is a ticking time bomb. What it means for the industry and your career.
Read article →